La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Dis-Chem Pharmacies Crescita futura

Future criteri di controllo 3/6

Dis-Chem Pharmacies prevede che gli utili e i ricavi cresceranno rispettivamente di 16.1% e 10.8% all'anno. Si prevede che l'EPS crescerà di 16.2% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 25.2% in 3 anni.

Informazioni chiave

16.1%

Tasso di crescita degli utili

16.2%

Tasso di crescita dell'EPS

Consumer Retailing crescita degli utili	14.2%
Tasso di crescita dei ricavi	10.8%
Rendimento futuro del capitale proprio	25.2%
Copertura analitica	Good
Ultimo aggiornamento	12 Aug 2024

Aggiornamenti recenti sulla crescita futura

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25

Recent updates

Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Jun 06

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09

Previsioni di crescita degli utili e dei ricavi

JSE:DCP - Stime future degli analisti e dati finanziari passati (ZAR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
2/28/2027	50,119	1,586	2,004	3,000	6
2/28/2026	44,751	1,322	1,525	2,631	6
2/28/2025	40,126	1,109	1,462	2,643	6
2/29/2024	36,283	984	863	1,890	N/A
11/30/2023	35,237	942	869	1,722	N/A
8/31/2023	34,191	899	876	1,555	N/A
5/31/2023	33,427	949	553	1,437	N/A
2/28/2023	32,664	1,000	230	1,320	N/A
11/30/2022	32,231	1,020	440	1,446	N/A
8/31/2022	31,798	1,040	650	1,572	N/A
5/31/2022	31,102	946	1,054	1,704	N/A
2/28/2022	30,407	853	1,459	1,836	N/A
11/30/2021	29,407	815	1,638	1,985	N/A
8/31/2021	28,407	776	1,817	2,134	N/A
5/31/2021	27,343	722	1,289	1,649	N/A
2/28/2021	26,278	669	762	1,164	N/A
11/30/2020	25,611	655	822	1,212	N/A
8/31/2020	24,944	641	882	1,260	N/A
5/31/2020	24,464	620	1,021	1,392	N/A
2/29/2020	23,984	598	1,160	1,523	N/A
11/30/2019	23,394	573	750	1,157	N/A
8/31/2019	22,803	549	339	792	N/A
5/31/2019	22,111	634	416	839	N/A
2/28/2019	21,420	719	493	887	N/A
11/30/2018	20,898	718	542	918	N/A
8/31/2018	20,376	718	591	948	N/A
5/31/2018	19,928	701	399	765	N/A
2/28/2018	19,480	684	208	581	N/A
11/30/2017	18,919	715	N/A	910	N/A
8/31/2017	18,359	746	N/A	1,239	N/A
5/31/2017	17,814	679	N/A	1,154	N/A
2/28/2017	17,268	612	N/A	1,069	N/A
11/30/2016	16,794	548	N/A	628	N/A
8/31/2016	16,320	484	N/A	187	N/A
5/31/2016	15,691	498	N/A	278	N/A
2/29/2016	15,061	513	N/A	369	N/A
2/28/2015	12,911	434	N/A	-22	N/A
2/28/2014	10,321	409	N/A	455	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di DCP ( 16.1% all'anno) è superiore al tasso di risparmio ( 9.7% ).

Guadagni vs Mercato: Si prevede che gli utili di DCP ( 16.1% all'anno) cresceranno più lentamente rispetto al mercato ZA ( 19.5% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di DCP cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di DCP ( 10.8% all'anno) crescerà più rapidamente del mercato ZA ( 3.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di DCP ( 10.8% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di DCP sarà elevato tra 3 anni ( 25.2 %)

Dis-Chem Pharmacies Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased by 7.9% to R33.02

Price target increased by 11% to R27.72

Price target decreased by 7.6% to R27.38

Price target decreased by 8.5% to R31.10

Price target decreased by 9.6% to R33.00

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Recent updates

Insider recently sold R854k worth of stock

Now 9.7% overvalued after recent price rise

Now 21% overvalued after recent price rise

Upcoming dividend of R0.22 per share

Price target increased by 7.9% to R33.02

Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Full year 2024 earnings: EPS misses analyst expectations

First half dividend of R0.22 announced

Now 26% overvalued after recent price rise

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Now 20% overvalued after recent price rise

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dis-Chem Pharmacies Limited, Annual General Meeting, Jul 31, 2024

Upcoming dividend of R0.23 per share at 1.4% yield

Price target increased by 11% to R27.72

First half 2024 earnings released: EPS: R0.58 (vs R0.70 in 1H 2023)

Dis-Chem Pharmacies Limited(JSE:DCP) dropped from FTSE All-World Index (USD)

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Dis-Chem Pharmacies Limited (JSE:DCP) acquired Berea Pharmacy.

Upcoming dividend of R0.18 per share at 1.6% yield

Price target decreased by 7.6% to R27.38

Full year 2023 earnings: EPS misses analyst expectations

Dis-Chem Pharmacies Limited Announces Gross Final Cash Dividend for the Period Ended 28 February 2023, Payable from 12 June 2023

Dis-Chem Pharmacies Limited Announces Executive Changes, Effective July 1, 2023

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Price target decreased by 8.5% to R31.10

Price target decreased by 9.6% to R33.00

Dis-Chem Pharmacies Limited to Report Fiscal Year 2023 Results on May 19, 2023

Executive Director exercised options to buy R96k worth of stock.

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

High number of new directors

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited to Report First Half, 2023 Results on Nov 02, 2022

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Now 20% undervalued

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Insider recently sold R25m worth of stock

Insider recently sold R10m worth of stock

Now 20% undervalued after recent price drop

High number of new directors

Now 20% undervalued after recent price drop

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Upcoming dividend of R0.20 per share

Dis-Chem Pharmacies Limited Declares Final Dividend for the Financial Year 2022

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Dis-Chem Pharmacies Limited Declares Final Dividend for the Financial Year 2022

Full year 2022 earnings: Revenues in line with analyst expectations

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Alternate Executive Director recently sold R47m worth of stock

Dis-Chem Pharmacies Limited to Report Fiscal Year 2022 Results on May 23, 2022

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Insider recently sold R183m worth of stock

High number of new directors

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Insider recently sold R60m worth of stock

Upcoming dividend of R0.19 per share

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

First half 2022 earnings released: EPS R0.48 (vs R0.36 in 1H 2021)

Dis-Chem Pharmacies Limited (JSE:DCP) acquired Medicare Hospital Equipment (Pty) Ltd from existing shareholders.

Royal Bafokeng Holdings (Pty) Limited, Global Capital Empowerment Fund, Zungu Pharmaceuticals and Temo Capital completed the acquisition of 10.05% stake in Dis-Chem Pharmacies Limited (JSE:DCP) from Saltzman Family Trust.

Full year 2021 earnings released: EPS R0.78 (vs R0.70 in FY 2020)